CRISPR gRNA Activity Validation in Precision Animal Breeding
- By Species
-
Animal Breeding and Genetics
- Animal Reproduction
- Animal Breeding Solutions
-
Animal Omics Solutions
- Animal Nucleic Acid Extraction and Purification
- Animal Genome Sequencing
- Animal Genotyping
- Animal Epigenomics Solutions
- Animal Transcriptomics Solutions
- Animal Proteomics Solutions
-
Animal Metabolomics Solutions
- Animal Non-targeted Metabolomics
- Animal Blood & Plasma & Serum Metabolomics
- Animal Urine Metabolomics
- Animal Saliva Metabolomics
- Animal Milk Metabolomics
- Animal Cerebrospinal Fluid Metabolomics
- Animal Gastric Fluid Metabolomics
- Animal Bile Metabolomics
- Animal Gastrointestinal Contents Metabolomics
- Animal Feces Metabolomics
- Animal Tissue Metabolomics
- Animal Cell Metabolomics
- Animal Amniotic Fluid Metabolomics
- Animal Follicular Fluid Metabolomics
- Animal Gut Microbiota Metabolomics
- Animal Targeted Metabolomics
- Animal Untargeted Lipidomics
- Animal Widely Targeted Metabolomics
- Animal Metabolomic Data Analysis
- Animal Non-targeted Metabolomics
- Animal Microbiome Solutions
-
Animal Health and Veterinary Biologicals Development
-
Veterinary Diagnostics Development
- Veterinary Immunodiagnostics Development
- Veterinary Molecular Diagnostics Development
- Animal Urinalysis Development
-
Veterinary Diagnostics Solution
- Veterinary Infectious Disease Diagnostics Development
- Pet Oncology Diagnostics Development
- Pet Allergy Diagnostics Development
- Animal Metabolic Disorder Diagnostics Development
- Animal Fertility Diagnostics Development
- Animal Toxicology Diagnostics Development
- Animal Nephropathy Diagnostics Development
- Animal Hepatopathy Diagnostics Development
- Animal Cardiovascular Disease Diagnostics Development
- Veterinary Infection Pathology Solutions
- Veterinary Bacterial Pathogen Solutions
- Veterinary Viral Pathogen Solutions
- Veterinary Fungal Pathogen Solutions
- Veterinary AMR Solutions
-
Veterinary Vaccine Development
- Live Attenuated Veterinary Vaccine Development
- Gene-Deleted Attenuated Veterinary Vaccine Development
- Recombinant Vectored Veterinary Vaccine Development
- Inactivated Veterinary Vaccine Development
- Whole Cell Bacterin Veterinary Vaccine Development
- Recombinant Subunit Veterinary Vaccine Development
- Virus-like Particle Veterinary Vaccine Development
- Toxoid Veterinary Vaccine Development
- DNA Veterinary Vaccine Development
- RNA Veterinary Vaccine Development
- Phage-based Veterinary Vaccine Development
- Combined Veterinary Vaccine Development
- Antigen Solution for Veterinary Vaccine Development
- Formulation Solution for Veterinary Vaccine Development
- In Vitro Assays for Veterinary Vaccine Development
- In Vivo Assays for Veterinary Vaccine Development
- Contract Veterinary Vaccine Manufacturing
- Veterinary Viral Vaccine Development
- Veterinary Bacterial Vaccine Development
- Veterinary Protozoal and Rickettsial Vaccine Development
- Veterinary Parasitic Vaccine Development
- Veterinary Fungal Vaccine Development
- Animal Immunocastration Vaccine Development
- Companion Animal Cancer Vaccine Development
- Veterinary Biological Therapeutics Development
-
Veterinary Diagnostics Development
-
Animal Nutrition and Feed Development
-
Animal Nutrition and Metabolism Solution
- Animal Nutrition and Metabolism Analysis
- Omics Solution in Animal Nutrition and Metabolism
- Animal Nutrition and Metabolism In Vitro Model Development
- Animal Nutrition and Metabolism In Vivo Model Development
- Animal Digestion and Absorption Solution
- Animal Nutritional and Metabolic Disorder Solution
- Swine Nutrition and Metabolism Solution
- Bovine Nutrition and Metabolism Solution
- Small Ruminant Nutrition and Metabolism Solution
- Poultry Nutrition and Metabolism Solution
- Aquaculture Species Nutrition and Metabolism Solution
- Canine Nutrition and Metabolism Solution
- Feline Nutrition and Metabolism Solution
- Equine Nutrition and Metabolism Solution
- Animal Feed Development
- Animal Feed and Animal-Derived Food Safety
-
Animal Nutrition and Metabolism Solution
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CRISPR gRNA Activity Validation in Precision Animal Breeding
Inquiry NowHow efficiently CRISPR system works largely depends on the sgRNA. BioVenic provides gRNA activity detection services in order to address the uncertainty of candidate sgRNAs. Our services utilize a range of sgRNA screening technologies, which allows researchers to identify the most appropriate sgRNA before delivering genome editing tools to living animal cells.
Fig.1 Schematic Diagram of the CRISPR Genome Editing System. (BioVenic Original)
Services of gRNA Activity Verification
Single-strand Annealing (SSA) Assay
Single-strand annealing (SSA) assay can verify the editing ability of gRNA editing vectors for naked DNA and is a common method for the preliminary evaluation of gRNA activity. The reporter plasmid in the SSA assay contains two non-active luciferase coding fragments. After efficient cleavage to form DNA double-strand breaks, the luciferase coding fragment will be repaired through homologous recombination using the SSA mechanism. BioVenic initially assesses the activity of the gRNA solely through fluorescence detection.
In Vitro Cleavage Assay
The editing efficiency of the CRISPR system is related to gRNA. A target gene has multiple editable targets. Different targets can be designed with corresponding gRNAs, and their cleavage activities may vary. Therefore, it is necessary to screen out the gRNA with the highest cleavage efficiency. BioVenic conducts in vitro testing to evaluate the editing activity of various gRNAs. By utilizing the Cas enzyme to cleave DNA sequences in vitro and measuring the percentage of gRNA-mediated DNA cleavage, we will readily assess the activity and efficiency of gRNAs for our customers.
In Vivo Cleavage Assay
BioVenic uses a mismatch endonuclease assay to detect the endogenous activity of gRNAs. Utilizing the functional characteristics of T7E1 endonuclease to identify and cleave mismatched hybrid DNA double strands, the design of primers on both sides of the target site is necessary for PCR amplification. We only need to estimate the ratio of enzyme-cleaved bands to un-cleaved bands in order to assess the endogenous activity of the gRNA.
Comparison of Different Activity Validation Services
Services | Contents | Features of the Assay |
---|---|---|
SSA Assay |
1. Design and synthesis of gRNA target primers. 2. Construction of pSSA-luc vector. 3. Cell Transfection. |
Simple design, easy operation and remarkable effect. |
In vitro Cleavage Assay |
1. In vitro transcription of gRNAs. 2. CRISPR/Cas in vitro enzyme digestion reaction. |
Only target primer design is required, no cell platform support is required, and low cost. |
In vivo Cleavage Assay |
1. Genome extraction. 2. Target primer design. 3. T7E1 enzyme digestion reaction. |
The screening cycle is short and closer to the situation during editing. |
Why Choose Us?
Multi-faceted one-stop gRNA activity validation.
Sufficient pre-experimental screening and evaluation of gRNA.
Reduce the impact of inefficient editing on project schedules.
Comprehensive customization services for gRNAs in precise animal genome editing.
BioVenic relies on its de novo gene synthesis platform, comprehensive molecular biology laboratory, and high-throughput sequencing technology to rapidly validate the editing activity of gRNA in the CRISPR system for farmed animals. Through three evaluation techniques, the efficiency of editing is systematically and comprehensively verified at three different levels. By customizing your gRNA validation service, you can easily obtain the best editing tools and significantly advance the research progress of animal precision breeding projects. Please feel free to contact us for intuitive gRNA activity verification results.
Reference
- Karmakar, Subhasis, et al. "In vitro Cas9 cleavage assay to check guide RNA efficiency." CRISPR-Cas Methods: Volume 2 (2021): 23-39.